Executive Director, ADME and Analytical Chem @ (June 2023 - October 2025)
Director, Head of Analytical Chemistry and ADME @ (April 2020 - December 2023)
Director, Bioanalytical and ADME Research @ (November 2015 - March 2020)
Scientific Manager @ (August 2013 - October 2015)
Associate Director, BA and DMPK @ Achaogen (March 2006 - July 2012)
Research Scientist @ (October 1998 - February 2006)
Senior Research Associate @ Axys Pharmaceuticals (May 1991 - October 1998)
SRA @ Arris Pharmaceutical (January 1991 - January 1996)
SRA @ Arris (January 1991 - January 1994)
Research Associate @ La Jolla Cancer Research Foundation (October 1987 - October 1990)
Bob Cass Education
UC San Diego
Chemistry (Biochemistry)
Bob Cass Skills
Bioanalysis
Drug Discovery
Biotechnology
Drug Development
IND
LC-MS
GLP
HPLC
Lifesciences
Pharmacokinetics
Assay Development
ADME
In Vivo
In Vitro
Chromatography
Mass Spectrometry
Clinical Development
Analytical Chemistry
Pharmacology
Pharmaceutical Industry
Technology Transfer
ELISA
Drug Design
DMPK
Biomarkers
Immunoassays
CRO
Infectious Diseases
Validation
Regulatory Submissions
Sop
UV/Vis
GMP
Small Molecules
Protocol
Toxicology
Biomarker Discovery
Drug Metabolism
Formulation
Clinical Trials
Protein Chemistry
Biopharmaceuticals
Pharmacodynamics
21 CFR Part 11
Translational Research
Laboratory Automation
Purification
Medicinal Chemistry
High Throughput Screening
Clinical Study Design
Microsoft Word
Lc Ms
Sales
Leadership
Project Management
Customer Service
Public Speaking
Bob Cass Summary
Bob Cass, based in San Rafael, CA, US, is currently a Vice President, DMPK and Analytical Chemistry at Nurix Therapeutics. Bob Cass brings experience from previous roles at Nurix Therapeutics, Ultragenyx Pharmaceutical Inc. and Genentech. Bob Cass holds a Chemistry in Biochemistry @ UC San Diego. With a robust skill set that includes Bioanalysis, Drug Discovery, Biotechnology, Drug Development, IND and more. Bob Cass has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Bob Cass?
Find contact details for 700 million professionals.